American Research & Management Company’s Zimmer Biomet ZBH Stock Holding History

American Research & Management Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-26	Closed	-$4K	–	395
2020 Q4	$4K	Buy	+26	New	+$3.67K	﹤0.01%	341
2019 Q2	–	Sell	-103	Closed	-$13K	–	376
2019 Q1	$13K	Hold	103	–	–	﹤0.01%	312
2018 Q4	$10K	Hold	103	–	–	﹤0.01%	274
2018 Q3	$13K	Hold	103	–	–	﹤0.01%	281
2018 Q2	$11K	Hold	103	–	–	﹤0.01%	268
2018 Q1	$11K	Buy	+103	New	+$12K	﹤0.01%	296
2017 Q1	–	Sell	-630	Closed	-$63K	–	345
2016 Q4	$63K	Buy	+630	New	+$67.5K	0.02%	161
2016 Q3	–	Sell	-630	Closed	-$77.8K	–	151
2016 Q2	$74K	Hold	630	–	–	0.03%	143
2016 Q1	$65K	Hold	630	–	–	0.03%	152
2015 Q4	$63K	Buy	+630	New	+$61.6K	0.03%	156

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Research & Management Company's ZBH Position: Q1 2021 in Review

American Research & Management Company sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 26 shares — an estimated $4K sold.

American Research & Management Company first reported a position in ZBH in Q4 2015 and held it in 10 quarters. The position peaked at $74K in Q2 2016. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

American Research & Management Company reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
American Research & Management Company sold 26 Zimmer Biomet shares in Q1 2021, an estimated $4K.
American Research & Management Company first reported a position in Zimmer Biomet in Q4 2015 and held it in 10 quarters.
American Research & Management Company's Zimmer Biomet position peaked at $74K in Q2 2016.
1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on American Research & Management Company's 13F filing for Q1 2021, filed 6 Apr 2021.